Increasing dimethylarginine levels are associated with adverse clinical outcome in severe alcoholic hepatitis
Authors:
- Rajeshwar P. MookerjeeRMRajeshwar P. Mookerjee
- Neil R. DaltonNDNeil R. Dalton
- Rajiv JalanRJRajiv Jalan
Open Access
- 22 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 45 (1) , 62-71
Abstract
Previous studies suggest reduced hepatic endothelial nitric oxide synthase activity contributes to increased intrahepatic resistance. Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, undergoes hepatic metabolism via dimethylarginine-dimethylamino-hydrolase, and is derived by the action of protein-arginine-methyltransferases. Our study assessed whether ADMA, and its stereo-isomer symmetric dimethylarginine (SDMA), are increased in alcoholic hepatitis patients, and determined any relationship with severity of portal hypertension (hepatic venous pressure gradient measurement) and outcome. Fifty-two patients with decompensated alcoholic cirrhosis were studied, 27 with acute alcoholic hepatitis and cirrhosis, in whom hepatic venous pressure gradient was higher ( P = 0.001) than cirrhosis alone, and correlated with ADMA measurement. Plasma ADMA and SDMA were significantly higher in alcoholic hepatitis patients and in nonsurvivors. Dimethylarginine-dimethylamino-hydrolase protein expression was reduced and protein-arginine-methyltransferase-1 increased in alcoholic hepatitis livers. ADMA, SDMA and their combined sum, which we termed a dimethylarginine score, were better predictors of outcome compared with Pugh score, MELD and Maddrey's discriminant-function. Conclusion: Alcoholic hepatitis patients have higher portal pressures associated with increased ADMA, which may result from both decreased breakdown (decreased hepatic dimethylarginine-dimethylamino-hydrolase) and/or increased production. Elevated dimethylarginines may serve as important biological markers of deleterious outcome in alcoholic hepatitis. (Hepatology 2007;45:62–71.)Keywords
This publication has 36 references indexed in Scilit:
- Influence of Hepatic Venous Pressure Gradient on the Prediction of Survival of Patients With Cirrhosis in the MELD Era *Hepatology, 2005
- Low–Grade Steatosis and Major Changes in Portal Flow As New Prognostic Factors in Steroid–Treated Alcoholic HepatitisHepatology, 2004
- Current management of alcoholic liver diseaseAlimentary Pharmacology & Therapeutics, 2004
- The liver is an important organ in the metabolism of asymmetrical dimethylarginine (ADMA)Clinical Nutrition, 2003
- Nitric Oxide and Portal HypertensionMetabolic Brain Disease, 2002
- The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enoughHepatology, 2002
- Biological significance of endogenous methylarginines that inhibit nitric oxide synthasesCardiovascular Research, 1999
- Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic ratsHepatology, 1998
- Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: Endothelial dysfunction in portal hypertensionGastroenterology, 1998
- Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolaseBritish Journal of Pharmacology, 1996